Related Experiment Video
Updated: May 20, 2026

Application of CRISPR Interference (CRISPRi) for Gene Silencing in Pathogenic Species of Leptospira
Published on: August 14, 2021
OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp
Luis G V Fernandes1, Monica L Vieira, Karin Kirchgatter
1Centro de Biotecnologia, Instituto Butantan, Avenida Vital Brazil, São Paulo, Brazil.
Abstract:
Leptospirosis is a zoonosis with multisystem involvement caused by pathogenic strains of the genus Leptospira. OmpL1 is an outer membrane protein of Leptospira spp. that is expressed during infection. In this work, we investigated novel features of this protein. We describe that OmpL1 is a novel leptospiral extracellular matrix (ECM)-binding protein and a plasminogen (PLG) receptor. The recombinant protein was expressed in Escherichia coli BL21(DE3) Star/pLysS as inclusion bodies, refolded, and purified by metal-chelating chromatography. The protein presented a typical β-strand secondary structure, as evaluated by circular dichroism spectroscopy. The recombinant protein reacted with antibodies in serum samples from convalescent leptospirosis patients with a high specificity compared to serum samples from individuals with unrelated diseases. These data strengthen the usefulness of OmpL1 as a diagnostic marker of leptospirosis. The characterization of the immunogenicity of recombinant OmpL1 in inoculated BALB/c mice showed that the protein has the capacity to elicit humoral and cellular immune responses, as denoted by high antibody titers and the proliferation of lymphocytes. We demonstrate that OmpL1 has the ability to mediate attachment to laminin and plasma fibronectin, with K(D) (equilibrium dissociation constant) values of 2,099.93 ± 871.03 nM and 1,239.23 ± 506.85 nM, respectively. OmpL1 is also a PLG receptor, with a K(D) of 368.63 ± 121.23 nM, capable of generating enzymatically active plasmin. This is the first report that shows and characterizes OmpL1 as an ECM-interacting and a PLG-binding protein of Leptospira spp. that may play a role in bacterial pathogenesis when expressed during infection.
Insights
Leptospira outer membrane protein OmpL1 binds extracellular matrix and plasminogen, aiding leptospirosis diagnosis and pathogenesis. This study characterizes OmpL1's role in bacterial infection and immune response.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- Leptospirosis is a bacterial zoonosis caused by Leptospira.
- OmpL1 is an outer membrane protein expressed by Leptospira during infection.
Purpose of the Study:
- To investigate novel features of Leptospira outer membrane protein 1 (OmpL1).
- To characterize OmpL1 as an extracellular matrix (ECM)-binding protein and plasminogen (PLG) receptor.
- To evaluate OmpL1's diagnostic potential and immunogenicity.
Main Methods:
- Recombinant OmpL1 expression and purification.
- Circular dichroism spectroscopy for secondary structure analysis.
- ELISA for antibody detection in patient sera.
- Immunization of BALB/c mice to assess immune response.
- Binding assays to quantify OmpL1 interaction with ECM components and plasminogen.
Main Results:
- OmpL1 exhibits a predominantly β-strand secondary structure.
- Recombinant OmpL1 specifically reacts with antibodies from leptospirosis patients.
- OmpL1 elicits humoral and cellular immune responses in mice.
- OmpL1 binds laminin and fibronectin with high affinity.
- OmpL1 functions as a plasminogen receptor, generating active plasmin.
Conclusions:
- OmpL1 is a novel ECM-binding and plasminogen-receptor protein in Leptospira.
- OmpL1's interactions may contribute to leptospiral pathogenesis.
- OmpL1 shows significant potential as a diagnostic marker for leptospirosis.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Formation of Lipopolysaccharides
Complement System
Bacterial Phylum Spirochaetes
Plasmids
Protein Transport to the Outer Chloroplast Membrane
Two models describe the mechanism of precursor recognition and entry across the outer membrane through the TOC complex. Model 1 suggests the newly synthesized precursor binds to the TOC receptor 159 and forms a complex.

